BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7779651)

  • 1. The metabolic and cardiovascular consequences of HRT.
    Stevenson JC
    Br J Clin Pract; 1995; 49(2):87-90. PubMed ID: 7779651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases].
    Kuhl H
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of hormone replacement therapy.
    Stevenson JC
    J Br Menopause Soc; 2004 Dec; 10(4):157-61. PubMed ID: 15667752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and the cardiovascular system. Nonlipid effects.
    Stevenson JC; Crook D; Godsland IF; Collins P; Whitehead MI
    Drugs; 1994; 47 Suppl 2():35-41. PubMed ID: 7517832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU; Ridker PM; Manson JE
    Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body fat distribution, the menopause transition, and hormone replacement therapy.
    Tchernof A; Poehlman ET; Després JP
    Diabetes Metab; 2000 Feb; 26(1):12-20. PubMed ID: 10705099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of the menopause and oestrogen replacement.
    Stevenson JC
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):449-67. PubMed ID: 8931905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases].
    Grand A
    Ann Cardiol Angeiol (Paris); 1998; 47(7):481-7. PubMed ID: 9772970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
    Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
    J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease in women: implications of hormone replacement therapy.
    Sarrel PM
    Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
    Thunell L; Andersson B; Glassell M; Mattsson LA
    Maturitas; 2006 Mar; 53(4):430-8. PubMed ID: 16198072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.